DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,827,210 | -15.9% | 104,100 | -18.6% | 0.07% | -40.5% |
Q2 2023 | $30,705,120 | +45.6% | 127,938 | +52.9% | 0.11% | -64.9% |
Q1 2023 | $21,088,439 | +77.5% | 83,671 | +86.9% | 0.32% | +45.6% |
Q4 2022 | $11,882,323 | -44.4% | 44,768 | -45.9% | 0.22% | -46.8% |
Q3 2022 | $21,377,000 | +45.9% | 82,766 | +43.2% | 0.41% | +1.0% |
Q2 2022 | $14,649,000 | -56.2% | 57,784 | -49.3% | 0.40% | -54.8% |
Q1 2022 | $33,425,000 | +3.3% | 113,950 | +15.9% | 0.89% | -11.1% |
Q4 2021 | $32,352,000 | +64.1% | 98,331 | +51.9% | 1.00% | +79.8% |
Q3 2021 | $19,714,000 | +9.3% | 64,754 | -3.7% | 0.56% | -9.1% |
Q2 2021 | $18,037,000 | +587.9% | 67,212 | +477.1% | 0.62% | +304.6% |
Q1 2021 | $2,622,000 | -7.4% | 11,647 | -8.6% | 0.15% | -19.6% |
Q4 2020 | $2,831,000 | +60.4% | 12,745 | +10.8% | 0.19% | +64.3% |
Q4 2019 | $1,765,000 | -61.0% | 11,500 | -63.3% | 0.12% | -57.2% |
Q3 2019 | $4,521,000 | +182.4% | 31,300 | +179.5% | 0.27% | +52.8% |
Q2 2019 | $1,601,000 | -15.8% | 11,200 | -22.2% | 0.18% | -43.8% |
Q1 2019 | $1,901,000 | – | 14,400 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |